TE_20684
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_F |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 244.58 |
| Counts of samples | TCGA_tumor:216; TCGA_normal:0; GTEx:0 |
| TSS | chr9(+):88625735 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_20684.1 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88642367,88642387 |
| teRNA_20684.2 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88629186,88629206 |
| teRNA_20684.3 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88629126,88629146 |
| teRNA_20684.4 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88652106,88652126 |
| teRNA_20684.5 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88652106,88652254,88652336,88652356 |
| teRNA_20684.6 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88652336,88652356 |
| teRNA_20684.7 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88628265,88628285 |
| teRNA_20684.8 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88628427,88628447 |
| teRNA_20684.9 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627542,88627728,88652189,88652209 |
| teRNA_20684.10 | - | Intergenic | Non-coding | Non-coding | chr9(+):88625736,88626187,88627546,88627728,88652106,88652126 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
